MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
1.990
-0.260
-11.56%
Opening 14:23 03/12 EDT
OPEN
2.130
PREV CLOSE
2.250
HIGH
2.320
LOW
1.900
VOLUME
204.15K
TURNOVER
79.39M
52 WEEK HIGH
74.00
52 WEEK LOW
1.900
MARKET CAP
1.33M
P/E (TTM)
-0.0130
1D
5D
1M
3M
1Y
5Y
1D
Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval
TipRanks · 2d ago
Biodexa Announces Outcome Of Type C Meeting With FDA Regarding The Phase 3 Program For eRapa In FAP; Clears The Way To Finalize Phase 3 Protocol And Recruit Sites For U.S.
Benzinga · 2d ago
Biodexa Pharmaceuticals announces outcome of a Type C meeting with FDA on eRapa
TipRanks · 2d ago
Weekly Report: what happened at BDRX last week (0303-0307)?
Weekly Report · 2d ago
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Barchart · 2d ago
Biodexa Announces Appointment Of Precision For Medicine As Clinical Research Organization For European Component Of Phase 3 Study Of eRapa In Familial Adenomatous Polyposis
Benzinga · 6d ago
Biodexa Pharmaceuticals announces appointment of Precision for Medicine as CRO
TipRanks · 6d ago
Weekly Report: what happened at BDRX last week (0224-0228)?
Weekly Report · 03/03 11:18
More
About BDRX
More
Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.
Recently
Symbol
Price
%Change

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.